David Domzalski is the founder of VYNE Therapeutics. VYNE Therapeutics has raised $88M in total funding. Latest round: Growth. Backed by Access Biotechnology.
David Domzalski is the Chief Executive Officer of VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for chronic inflammatory and immune-mediated conditions. He previously discussed the company's $88M private placement (PIPE) transaction. VYNE Therapeutics was formerly known as Menlo Therapeutics Inc. before renaming in September 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library